Both tocotrienols also prevented the increase in sclerostin and DKK-1 levels in the animals with metabolic syndrome, which negatively regulate the activation of Wnt/β-catenin by preventing the binding of Wnt ligands to the frizzled receptor, lipoprotein receptor-related protein 5/6 [90]. This evidence concerns the gene SOST and metabolic syndrome.